|
|
Logistic regression analysis of cerebral microbleeds risk factors of patients with non-valvular atrial fibrillation and cerebral infarction |
WU Yijie1 SHEN Jiahui1 ZHOU Yi2 ZHAO Heqing3 ZHOU Lihui1▲ |
1.Department of Neurology, Suzhou Science and Technology Town Hospital, Jiangsu Province, Suzhou 215153, China;
2.Department of Neurology, the Taicang Affiliated Hospital of Soochow University, Jiangsu Province, Taicang 215400, China;
3.Department of Neurology, the Second Affiliated Hospital of Soochow University, Jiangsu Province, Suzhou 215004, China |
|
|
Abstract Objective To analyze the cerebral microbleeds (CMB) risk factors of patients with non-valvular atrial fibrillation and cerebral infarction, and provide guidance for therapeutic schedule for these patients. Methods One hundred and seventeen patients with non-valvular atrial fibrillation and cerebral infarction were enrolled that treated in the Department of Neurology, the Taicang Affiliated Hospital of Soochow University from January 2014 to December 2016, that were divided into CMB group (48 cases) and non-CMB group (69 cases). The demographic characteristics, the common risk factors of stroke and laboratory examination indices were compared between the two groups. Results Among the 117 patients, 48 cases (41%) were detected with CMB; the average age of the CMB group was higher than the non-CMB group (P = 0.002) ; the homocyatein (Hcy) level of the CMB group was higher than the non-CMB group (P = 0.033) ; the low density lipoprotein (LDL-C) of the CMB group was lower than the non-CMB group (P = 0.037); all the differences were statistically significant. Through a Logistic regression analysis, elderly was independently associated with the presence of CMB (P = 0.07, OR = 1.079, 95%CI: 1.021-1.140). Conclusion There is a high prevalence of CMB in patients with non-valvular atrial fibrillation and cerebral infarction and the occurrence of CMB is mainly associated with elderly.
|
|
|
|
|
[1] Giralt-Steinhauer E,Cuadrado-Godia E,Ois A,et al. Comparison between CHADS2 and CHA2DS2-VASc score in a stroke cohort with atrial fibrillation [J]. Eur J Neurol,2013,20(4):623-628.
[2] 陈春,储照虎.非瓣膜性房颤患者预防脑栓塞的抗凝现状[J].国际老年医学杂志,2016,37(6):282-285.
[3] 吴章薇,梅丽平,赵军,等.心房颤动合并脑栓塞患者的抗凝治疗现状和出血转化分析[J].中国卒中杂志,2016, 11(1):47-53.
[4] Song TJ,Kim J,Song D,et al. Association of cerebral microbleeds with mortality in stroke patients having atrial fibrillation [J]. Neurology,2014,83(15):1308-1315.
[5] Orken DN,Kenangil G,Timer E,et al. New cerebral microbleeds in ischemic stroke patients on warfarin treatment: two-year follow-up [J]. Clin Neurol Neurosurg,2013, 115(9):1682-1685.
[6] Krishnan AS,Lansley JA,Jäger HR,et al. New vistas in clinical practice:susceptibility-weighted imaging [J]. Quant Imaging Med Surg,2015,5(3):448-452.
[7] Fazlollahi A,Meriaudeau F,Giancardo L,et al. Computer-aided detection of cerebral microbleeds in susceptibility-weighted imaging [J]. Comput Med Imaging Graph,2015, 46 Pt 3:269-276.
[8] Fisher M. MRI screening for chronic anticoagulation in atrial fibrillation [J]. Front Neurol,2013,4:137
[9] 吴小三,方传勤.CHADS2评分在非瓣膜病心房颤动患者发生缺血性脑卒中短期预后的预测价值[J].中华老年心脑血管病杂志,2015,17(10):1055-1057.
[10] 肖桂荣,孙新芳,王赵伟.脑微出血磁敏感加权成像检出情况及其与认知功能的关系[J].中国全科医学,2014, 17(21):2532-2535.
[11] Williams LS,Yilmaz EY,Lopez-Yunez AM. Retrospective assessment of initial stroke severity with the NIH Stroke Scale [J]. Stroke,2000,31(4):858-862.
[12] 万琛宜,黄经纬,洪道俊,等.急性缺血性卒中的出血性转化和转归:回顾性病例系列研究[J].国际脑血管病杂志,2013,21(3):161-165.
[13] Wahlgren N,Ahmed N,Eriksson N,et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials:Safe Implementation of Thrombolysis in Stroke-MOnitoring Study(SITS-MOST)[J]. Stroke,2008, 39(12):3316-3322.
[14] Campbell BC,Christensen S,Butcher KS,et al. Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke [J]. Stroke,2010,41(1):82-88.
[15] Lee SH,Ryu WS,Roh JK. Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage [J]. Neurology,2009,72(2):171-176.
[16] 孙迎雪,王丽娜,滕继军.缺血性卒中患者的脑微出血[J].国际脑血管病杂志,2015,23(10):777-780.
[17] Poels MM,Ikram MA,Van LA,et al. Incidence of cerebral microbleeds in the general population:the Rotterdam Scan Study [J]. Stroke,2011,42(3):656-661.
[18] 王本国,林棉,杨楠,等.急性缺血性脑血管病合并脑微出血的临床特征研究[J].中华神经医学杂志,2011,10(3):284-288.
[19] Jeon SB,Kang DW,Cho AH,et al. Initial microbleeds at MR imaging can predict recurrent intracerebral hemorrhage [J]. J Neurol,2007,254(4):508-512.
[20] Hackam DG,Woodward M,Newby LK,et al. Statins and intracerebral hemorrhage:collaborative systematic review and meta-analysis [J]. Circulation,2011,124(20):2233-2242.
[21] 曾婷婷,邱伟文,曾敏.血浆同型半胱氨酸水平与脑出血转归的相关性分析[J].浙江临床医学,2015,17(11):1914-1915.
[22] Jia SJ,Lai YQ,Zhao M,et al. Homocysteine-induced hypermethylation of DDAH2 promoter contributes to apoptosis of endothelial cells [J]. Pharmazie,2013,68(4):282-286.
[23] Portela A,Esteller M. Epigenetic modifications and human disease [J]. Nat Biotechnol,2010,28(10):1057-1068. |
|
|
|